Tag
This Wired article explores how AI could help detect fatty liver disease earlier by analyzing electronic health records and lab reports, potentially enabling prevention and reversal of liver damage.
MIT researchers developed injectable hydrogel microspheres that, combined with hepatocytes, form stable mini livers in mice, potentially offering a non-surgical alternative to liver transplantation.
DeepMind's Co-Scientist AI system helped researchers at the University of Edinburgh generate a novel, experimentally verified hypothesis linking the NLRP3 inflammasome to the mechanism of drug resmetirom in MASH liver disease, potentially enabling targeted combination therapies.